about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersSpironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic ratsMonocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetesEffect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease.Effect of telmisartan and enalapril on ventricular remodeling and kidney prognosis of patients with coronary artery disease complicated with diabetic nephropathy.NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Role of aldosterone in diabetic nephropathy.
@en
Role of aldosterone in diabetic nephropathy.
@nl
type
label
Role of aldosterone in diabetic nephropathy.
@en
Role of aldosterone in diabetic nephropathy.
@nl
prefLabel
Role of aldosterone in diabetic nephropathy.
@en
Role of aldosterone in diabetic nephropathy.
@nl
P2093
P2860
P1433
P1476
Role of aldosterone in diabetic nephropathy.
@en
P2093
Dae Ryong Cha
Hyoung Kyu Kim
Jee Young Han
Kum Hyun Han
Sang Youb Han
Yi Hwa Jee
Young Sik Kim
Young Sun Kang
P2860
P356
10.1111/J.1440-1797.2005.00455.X
P478
P577
2005-10-01T00:00:00Z